Celcuity, Inc. (CELC) vs Arcus Biosciences, Inc. (RCUS)
- Celcuity, Inc. CELC 56.16 −6.87%
- Arcus Biosciences, Inc. RCUS 22.12 −3.07%
Celcuity, Inc. and Arcus Biosciences, Inc. are both Biotechnology companies. Celcuity, Inc. and Arcus Biosciences, Inc. are of similar size ($3.0B and $2.9B). Celcuity, Inc. has the higher net margin (0.00% vs −393.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Celcuity, Inc. leads on 9 and Arcus Biosciences, Inc. on 3.
Valuation
Profitability
| Metric | CELC | RCUS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (415.38%) | 0.00% |
| Net margin | 0.00% | (393.16%) | 0.00% |
| Free cash flow margin | 0.00% | (405.13%) | 0.00% |
| Return on equity | (1,433.70%) | (90.82%) | (56.36%) |
| Return on assets | (44.77%) | (46.02%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack